Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Safiglipron

Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity

Shandong Suncadia Medicine Co · Phase 3 · Recruiting · Enrollment 648

NCT07528027

ArmPopulationDoseWeeksEstimandWeight change
Treatment group A: HRS-7535Obesity or overweightn/rn/rn/rn/r
Treatment group B: PlaceboObesity or overweightn/rn/rn/rn/r